Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 6382 matches for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

Oxford researchers awarded funding to pioneer ovarian cancer vaccine development

Ovarian cancer remains a devastating global health challenge: each year, over 300,000 women are diagnosed, and nearly 200,000 lives are lost, largely because the disease is detected at a late stage. Women carrying inherited genetic changes face a significantly elevated lifetime risk, over 40%, and current preventive strategies often require invasive surgery that compromises fertility. These limitations underscore an urgent need for non-surgical preventive options, and vaccines could offer a groundbreaking solution.

Bodleian Libraries Update - November 2025 - Global Health Archive | Covidence | Information Skills Courses

Iron supplement absorption preserved in children with HIV and boosted by prebiotics

New research shows that iron from supplements and fortified foods is well-absorbed in children living with virally suppressed HIV, and that administering iron supplements with prebiotics may enhance their effectiveness and improve their safety.

Oxford scientists map the cells that drive Crohn’s disease fistulas

Researchers at the MRC Translational Immune Discovery Unit have identified how rare populations of abnormal cells drive the formation and persistence of fistulas - painful, tunnel-like tracts that develop in around 30% of people with Crohn’s disease - paving the way for targeted treatments.

Hippocampus helps us learn to navigate unknown environments

A new study published in Nature Communications reveals how the hippocampus — a brain region crucial for memory and navigation — supports flexible learning when sensory information is uncertain or incomplete.

Oxford joins £15.9m national initiative to transform cancer research using live human tissue models

Oxford scientists are part of a new £15.9 million UK initiative to transform disease research through the development of advanced human tissue models. The INTREPID project will evaluate and optimise the use of live human tumour samples to enhance the accuracy of preclinical research, speed up drug discovery, and reduce dependence on animal testing.

Shame a significant factor in hairpulling in young people, new study finds

It found that shame partially explained the relationship between hairpulling and depression, and fully explained the relationship between hairpulling and anxiety.

Study shows kidney and heart benefits of SGLT2 inhibitors extend to all patients with chronic kidney disease

A new study led by researchers at Oxford Population Health has found that sodium-glucose co-transporter-2 (SGLT2) inhibitors provide major kidney and heart benefits for people with chronic kidney disease (CKD), regardless of whether they have diabetes or raised levels of albumin in their urine.

Professor Ellie Tzima receives €10m to investigate the neurovascular interface of peripheral nerves

Professor Ellie Tzima has been awarded a highly competitive European Research Council (ERC) Synergy Grant to investigate the enigmatic neurovascular interface of peripheral nerves – a critical but poorly understood junction between the nervous and vascular systems.

Children’s Surgery Outcome Reporting programme receives £3.7m investment

A unified, England-wide dataset will support research into improving the health and wellbeing of children with complex surgical conditions.

From pain to policy: global reviews call for urgent action on endometriosis in most world regions

First global mapping shows half the world’s countries lack policies or guidelines for endometriosis, affecting >200 million women and girls.

Oxford scientists capture genome’s structure in unprecedented detail

Radcliff Department of Medicine scientists have achieved the most detailed view yet of how DNA folds and functions inside living cells, revealing the physical structures that control when and how genes are switched on.

New Microbiome Innovation Network to drive UK Bioscience Research

Researchers from the Kennedy Institute are part of a UK-wide consortium that has been awarded a £644K BBSRC Network Grant to establish the Microbiome Innovation Network (Microbiome-Net).

New study to investigate link between gut microbiome and emotional and cognitive wellbeing in early menopause

The research will add to a growing body of evidence on the effects of probiotics on mood and cognition and their ability to positively affect menopausal symptoms.

Symposium honours the life and legacy of Professor Tipu Aziz

The Nuffield Department of Surgical Sciences (NDS) hosted a special symposium on Friday 17 October 2025 in honour of Professor Tipu Aziz (1956–2024), Emeritus Professor of Neurosurgery and founder and head of Oxford Functional Neurosurgery.

New research published: How the brain conquers the third dimension

Members of the Department of Physiology, Anatomy and Genetics (DPAG) are part of an international collaborative team that has published new research in Proceedings of the National Academy of Sciences.

The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences enhances surgical research capacity in Vietnam

Prof David Beard was the keynote speaker at a recent Surgical Trials Workshop in Ho Chi Minh City, Vietnam, contributing to improved treatment quality and greater international integration in healthcare and medical science.

New AI tool could improve prostate cancer treatment

A ground-breaking new study will test how artificial intelligence (AI) can make prostate cancer diagnosis more accurate. The study by the University of Oxford is funded by a £1.9m grant from research charity Prostate Cancer UK.

Terumo completes acquisition of University of Oxford spinout OrganOx for a record $1.5bn

OrganOx, a pioneering Oxford University spinout transforming kidney and liver transplantation, has been fully acquired by Terumo Corporation, a global medical technology company headquartered in Tokyo, Japan, for US$1.5 billion, marking the largest exit in Oxford University’s spinout portfolio to date and the first in excess of £1bn. The agreement for the acquisition was announced in August 2025.

Key blood test for identifying people with heart failure less accurate in those with atrial fibrillation, new study finds

A large new study led by researchers in the Nuffield Department of Primary Care Health Sciences has found that a common blood test used to help diagnose heart failure is less accurate in people who also have atrial fibrillation (AF).

Load More